Page 157 - Read Online
P. 157

Yang et al. Hepatoma Res 2019;5:13  I  http://dx.doi.org/10.20517/2394-5079.2019.04                                                  Page 3 of 9


               Table 1. Main characteristics of studies concerning tumor response rate between TACE with RFA vs. TACE alone
                              Year study was     Sample      TACE         Tumor     TACE + RFA    Tumor
                Ref.                     Gender
                               conducted          size    Total  Events  response rate  Total  Events  response rate
                Dong et al. [11]  2011-2012  Both  44     22      6     0.272727273  22    11   0.5
                Du et al. [12]  2015-2016  Both   80      40      14    0.35        40     23   0.575
                Ge and Zhang [13]  2008-2009  Both  43    24      12    0.5         19     14   0.736842105
                Kuang et al. [14]  2015-2017  Both  87    40      21    0.525       47     35   0.744680851
                Li et al. [15]  2012-2013  Both   80      42      21    0.5         38     27   0.710526316
                Liang [16]     2006-2008  Both    55      24      9     0.375       31     25   0.806451613
                Liu et al. [17]  2011-2013  Both  128     64      10    0.15625     64     22   0.34375
                Shen et al. [18]  2004-2005  Both  40     19      9     0.473684211  21    17   0.80952381
                Song et al. [19]  2006-2008  Both  29     15      4     0.266666667  14    11   0.785714286
                Zhang et al. [20]  2012-2014  Both  70    33      6     0.181818182  37    17   0.459459459
                Yang et al. [21]  2006-2008  Both  35     11      6     0.545454545  24    16   0.666666667


               duplicate reports of similar content by the same author, or if there are too few patients and unclear data; (4)
               the maximum diameter of tumor lesions is less than 5 cm.

               Data acquisition
               The literature and extracted the data were screened independently by authors. After articles were screened
               by their titles and abstracts, they were filtered by reading the full text. During the screening process, the
               literature was selected in strict accordance with the set inclusion and exclusion criteria. After the screening
               was completed, the articles were read again to verify that they meet the requirements.


               Statistical methods
               Statistical analysis was performed using Comprehensive Meta Analysis V2. Before the meta-analysis, the
                            2
               heterogeneity I  test of each test result was performed. If the homogeneity of each test included in the study
               was good (P > 0.05), the fixed effect model was used. If heterogeneity existed, the random effect model was
               used. A funnel chart was used to evaluate the bias risk of the inclusion test, and asymmetric funnel charts
               suggest that there may be publication bias.


               RESULTS
               Literature search results
               Manual search of electronic databases identified a total of 1,487 studies. After checking for duplicates,
               there were 1,304 remaining. A large number of these studies were excluded based upon our inclusion and
               exclusion criteria, leaving only 11 articles to be included in the meta-analysis [Figure 1 and Table 1].

               Tumor response rate
               There were 11 reports with tumor response rate data comparing TACE with RFA vs. TACE alone. Tumor
               response rate was measured by the proportion of patients with either complete or partial shrinkage of
               tumors. Since the heterogeneity test had a P = 0.983, the fixed-effects model was used. The results showed
               that the tumor response rate of TACE with RFA in the treatment of HCC was significantly superior to TACE
                                                                  2
               alone [risk ratio (RR) = 1.452, 95%CI: 1.308-1.610, P < 0.001, I  = 0%] [Figure 2].
               Six-month survival rate
               Six studies [15,16,18-21]  (involving 309 participants) compared the half-year survival of the TACE with RFA group
               vs. the TACE alone group. The results showed that half-year survival rate was higher in the TACE with RFA
                                                                                   2
               group than in the TACE alone group [RR = 1.257, 95%CI = 1.128-1.401, P < 0.001, I  = 0%] [Figure 3].
               One-year survival rate
               Eight studies [14-21]  (involving 524 participants) compared the 1-year survival of the TACE with RFA group vs.
               the TACE alone group. The results showed that 1-year survival rate was higher in the TACE with RFA group
                                                                                   2
               compared to the TACE alone group [RR = 1.412, 95%CI = 1.249-1.596, P < 0.001, I  = 0%] [Figure 4].
   152   153   154   155   156   157   158   159   160   161   162